NZ309172A - Neutralizing conformational epitopes of chicken anemia virus - Google Patents
Neutralizing conformational epitopes of chicken anemia virusInfo
- Publication number
- NZ309172A NZ309172A NZ309172A NZ30917296A NZ309172A NZ 309172 A NZ309172 A NZ 309172A NZ 309172 A NZ309172 A NZ 309172A NZ 30917296 A NZ30917296 A NZ 30917296A NZ 309172 A NZ309172 A NZ 309172A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cav
- genome
- infections
- compositions
- vaccine
- Prior art date
Links
- 241000725585 Chicken anemia virus Species 0.000 title abstract 10
- 230000003472 neutralizing effect Effects 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 229940031567 attenuated vaccine Drugs 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
- C12N2750/10062—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/480,020 US5932476A (en) | 1990-09-12 | 1995-06-07 | Cloning of chicken anemia virus DNA |
| PCT/NL1996/000230 WO1996040931A1 (en) | 1995-06-07 | 1996-06-07 | Neutralizing conformational epitopes of chicken anemia virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ309172A true NZ309172A (en) | 1999-11-29 |
Family
ID=23906352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ309172A NZ309172A (en) | 1995-06-07 | 1996-06-07 | Neutralizing conformational epitopes of chicken anemia virus |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0832242A1 (xx) |
| JP (1) | JPH11510367A (xx) |
| CN (1) | CN1194001A (xx) |
| AU (1) | AU720640B2 (xx) |
| CA (1) | CA2221570A1 (xx) |
| NZ (1) | NZ309172A (xx) |
| WO (1) | WO1996040931A1 (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192594B2 (en) | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| EP1037909B1 (en) * | 1997-12-11 | 2007-06-13 | University of Saskatchewan | Postweaning multisystemic wasting syndrome virus from pigs |
| JP2001275664A (ja) * | 2000-02-29 | 2001-10-09 | Akzo Nobel Nv | 低い病原性のニワトリ貧血ウイルス |
| AUPR567401A0 (en) | 2001-06-14 | 2001-07-12 | University Of Melbourne, The | Circovirus vaccines |
| JP2007524609A (ja) * | 2003-04-10 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | コンフォメーションに関する変種のプロファイリング、抗体組成物 |
| RU2662685C2 (ru) | 2013-09-25 | 2018-07-26 | Зоэтис Сервисиз Ллс | Pcv2b дивергентная вакцинная композиция и способы её применения |
| CN113897356B (zh) * | 2021-10-20 | 2024-04-30 | 佛山科学技术学院 | 一种检测鸡传染性贫血病毒荧光定量pcr试剂盒及引物 |
| CN118028252A (zh) * | 2024-04-15 | 2024-05-14 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 表达ciav vp1和vp2基因的重组鸡马立克病病毒疫苗株及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69101683T2 (de) * | 1990-07-30 | 1994-07-21 | Akzo Nv | Rekombinantes Mareks-Krankheitsvirus. |
| NL9301272A (nl) * | 1993-07-20 | 1995-02-16 | Aesculaap Bv | Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus. |
| NL9002008A (nl) * | 1990-09-12 | 1992-04-01 | Stichting Centr Diergeneeskund | Recombinant dna en rna en daarvan afgeleide produkten. |
| ZA918426B (en) * | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
-
1996
- 1996-06-07 AU AU59137/96A patent/AU720640B2/en not_active Ceased
- 1996-06-07 WO PCT/NL1996/000230 patent/WO1996040931A1/en not_active Application Discontinuation
- 1996-06-07 CA CA002221570A patent/CA2221570A1/en not_active Abandoned
- 1996-06-07 JP JP9500328A patent/JPH11510367A/ja active Pending
- 1996-06-07 NZ NZ309172A patent/NZ309172A/xx unknown
- 1996-06-07 EP EP96916379A patent/EP0832242A1/en not_active Withdrawn
- 1996-06-07 CN CN96195434A patent/CN1194001A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0832242A1 (en) | 1998-04-01 |
| CA2221570A1 (en) | 1996-12-19 |
| AU720640B2 (en) | 2000-06-08 |
| JPH11510367A (ja) | 1999-09-14 |
| WO1996040931A1 (en) | 1996-12-19 |
| AU5913796A (en) | 1996-12-30 |
| CN1194001A (zh) | 1998-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE194291T1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
| EP0835133A4 (en) | RECOMBINANT COMPOSITIONS AND COMBINED COMPOSITIONS OF RABIES AND SMALLPOX VIRUSES, AND USES THEREOF | |
| EP1016418A3 (en) | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule | |
| NO308413B1 (no) | Antigen blanding, DNA-segment som koder for et antigen, rekombinant vektor og vertscelle som innbefatter DNA-segmentet samt anvendelser av et antigen | |
| ATE453403T1 (de) | Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert | |
| WO1995006732A3 (en) | Bacterial exported proteins and acellular vaccines based thereon | |
| NZ309172A (en) | Neutralizing conformational epitopes of chicken anemia virus | |
| CA2144855A1 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| CA2091263A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| EP1253201A3 (en) | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor | |
| BR9106601A (pt) | Adjustante de vacina e processo de obter aumento da resposta imunologica a um antigeno em um ser humano ou animal | |
| HUP9801334A2 (hu) | A 18-as típusú humán papillomavírust kódoló DNS | |
| WO2021202599A3 (en) | Adeno-associated virus based compositions and related methods for inducing humoral immunity | |
| PT831899E (pt) | Composições de poxvírus-calicivírus recombinantes e suas utilizações | |
| AU3830995A (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| MX9709851A (es) | Epitopes neutralizadores conformacionales del virus de la anemia de pollo. | |
| AU5573196A (en) | A pluripotent vaccine against enveloped viruses | |
| DE69637833D1 (en) | Offe | |
| CA2286399A1 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| DE69126486D1 (de) | Induzierung eines schutzes gegen virale infektionen | |
| WO1999015692A3 (en) | Dengue virus antigens and treatment of dengue fever | |
| Watson et al. | General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices(ACIP), Morbidity and Mortaility Weekly Report, January 28, 1994. Volume 43, Number RR-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |